2.31
price down icon1.28%   -0.03
after-market Handel nachbörslich: 2.32 0.010 +0.43%
loading

Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten

pulisher
Mar 04, 2026

Earnings Recap: Is Tempest Therapeutics Inc stock a value trap2025 EndofYear Setup & Smart Swing Trading Techniques - baoquankhu1.vn

Mar 04, 2026
pulisher
Mar 04, 2026

IPO Launch: Is AMBIWS a strong candidate for buy and hold2025 Analyst Calls & Daily Technical Stock Forecast Reports - baoquankhu1.vn

Mar 04, 2026
pulisher
Mar 04, 2026

TPST Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 04, 2026
pulisher
Feb 27, 2026

Tempest Therapeutics, Inc. (TPST) Stock Forecast & Price Prediction 2026–2030 - CoinCodex

Feb 27, 2026
pulisher
Feb 26, 2026

Tempest Therapeutics, Inc.Common Stock (NQ: TPST - FinancialContent

Feb 26, 2026
pulisher
Feb 25, 2026

EX-99.1 - SEC.gov

Feb 25, 2026
pulisher
Feb 25, 2026

Tempest Therapeutics reports complete response in myeloma trial - Investing.com

Feb 25, 2026
pulisher
Feb 25, 2026

Tempest Therapeutics Advances TPST-2003 CAR-T with Strong Data - TipRanks

Feb 25, 2026
pulisher
Feb 25, 2026

Tempest reports 100% ORR in evaluable TPST-2003 patients, plans U.S. registrational study in 2026 - TradingView

Feb 25, 2026
pulisher
Feb 25, 2026

Tempest Therapeutics (TPST) reveals 100% response in TPST-2003 multiple myeloma study - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026 - Bitget

Feb 25, 2026
pulisher
Feb 25, 2026

Tempest myeloma cell therapy hits 100% response in 25 patients, US trial planned - Stock Titan

Feb 25, 2026
pulisher
Feb 25, 2026

Tempest Therapeutics reports complete response in myeloma trial By Investing.com - Investing.com Canada

Feb 25, 2026
pulisher
Feb 20, 2026

Why Tempest Therapeutics Inc. stock could outperform in 2025Weekly Profit Recap & Free Community Supported Trade Ideas - mfd.ru

Feb 20, 2026
pulisher
Feb 17, 2026

How Tempest Therapeutics Inc. stock reacts to global recession fearsMarket Sentiment Report & AI Enhanced Execution Alerts - mfd.ru

Feb 17, 2026
pulisher
Feb 16, 2026

Is Tempest Therapeutics Inc.’s growth already priced inBuy Signal & Daily Oversold Bounce Ideas - mfd.ru

Feb 16, 2026
pulisher
Feb 15, 2026

What catalysts could drive Tempest Therapeutics Inc. stock higher2025 Earnings Impact & Free High Return Stock Watch Alerts - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Will Tempest Therapeutics Inc. stock recover after earningsM&A Rumor & Advanced Swing Trade Entry Plans - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

TPST Should I Buy - Intellectia AI

Feb 14, 2026
pulisher
Feb 12, 2026

How cyclical is Tempest Therapeutics Inc.’s revenue streamEarnings Performance Report & Smart Swing Trading Techniques - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Tempest Therapeutics Highlights Partner-Funded CAR-T Oncology Pipeline - The Globe and Mail

Feb 12, 2026
pulisher
Feb 11, 2026

Tempest lays out strategic plan to advance recently acquired dual-targeting CAR-T assets - marketscreener.com

Feb 11, 2026
pulisher
Feb 11, 2026

Tempest Therapeutics outlines plans for acquired CAR T assets - bioworld.com

Feb 11, 2026
pulisher
Feb 11, 2026

Tempest Therapeutics, Inc. Updates on Oncology Pipeline and Clinical Progress - TradingView

Feb 11, 2026
pulisher
Feb 11, 2026

Partner-funded China trials anchor Tempest’s new CAR-T push - Stock Titan

Feb 11, 2026
pulisher
Feb 11, 2026

Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets - The Manila Times

Feb 11, 2026
pulisher
Feb 07, 2026

Key facts: Tempest Therapeutics announces management changes; issues warrants - TradingView

Feb 07, 2026
pulisher
Feb 06, 2026

Tempest Therapeutics Signs Warrant Agreement With Computershare - TradingView

Feb 06, 2026
pulisher
Feb 06, 2026

Tempest Therapeutics (NASDAQ: TPST) closes CAR T acquisition and names new CEO - Stock Titan

Feb 06, 2026
pulisher
Feb 05, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Feb 05, 2026
pulisher
Feb 05, 2026

Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets - The Manila Times

Feb 05, 2026
pulisher
Feb 04, 2026

Tempest Therapeutics completes acquisition of CAR-T assets By Investing.com - Investing.com Nigeria

Feb 04, 2026
pulisher
Feb 04, 2026

Tempest Therapeutics completes acquisition of CAR-T assets - Investing.com

Feb 04, 2026
pulisher
Feb 04, 2026

Tempest Therapeutics Closes All-Stock Transaction to Acquire Next-Generation CAR-T Assets and Appoints Matt Angel as CEO - Quiver Quantitative

Feb 04, 2026
pulisher
Feb 04, 2026

Cancer biotech Tempest retools around dual CAR-Ts and new CEO - Stock Titan

Feb 04, 2026
pulisher
Feb 04, 2026

Tempest Therapeutics (TPST) Price Target Increased by 22.22% to 11.22 - Nasdaq

Feb 04, 2026
pulisher
Feb 01, 2026

Tempest Therapeutics Announces New Leadership and Acquisition - MSN

Feb 01, 2026
pulisher
Jan 30, 2026

Will Tennessee Valley Authority benefit from AI trendsMarket Sentiment Summary & Weekly High Momentum Picks - baoquankhu1.vn

Jan 30, 2026
pulisher
Jan 28, 2026

What’s the outlook for Tempest Therapeutics Inc.’s sectorPortfolio Gains Report & Consistent Return Investment Signals - mfd.ru

Jan 28, 2026
pulisher
Jan 28, 2026

Tempest Therapeutics (NASDAQ: TPST) wins approval for rights plan, share issuance and equity pool - Stock Titan

Jan 28, 2026
pulisher
Jan 25, 2026

Investment Report: Is Tempest Therapeutics Inc stock a value trapJuly 2025 Final Week & Daily Stock Trend Watchlist - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 25, 2026

Aug Decliners: Is Tempest Therapeutics Inc stock a top performer YTD2025 EndofYear Setup & Risk Controlled Stock Pick Alerts - baoquankhu1.vn

Jan 25, 2026
pulisher
Jan 23, 2026

Tempest Therapeutics stock surges after H.C. Wainwright upgrade By Investing.com - Investing.com Australia

Jan 23, 2026
pulisher
Jan 22, 2026

Tempest Therapeutics stock surges after H.C. Wainwright upgrade - Investing.com

Jan 22, 2026
pulisher
Jan 22, 2026

H.C. Wainwright upgrades Tempest Therapeutics stock rating to Buy with $11 target - Investing.com India

Jan 22, 2026
pulisher
Jan 22, 2026

HC Wainwright & Co. Upgrades Tempest Therapeutics (TPST) - Nasdaq

Jan 22, 2026
pulisher
Jan 21, 2026

Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders - The Manila Times

Jan 21, 2026
pulisher
Jan 20, 2026

Inflation Data: Will Tempest Therapeutics Inc stock recover after earningsJuly 2025 Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn

Jan 20, 2026
pulisher
Jan 20, 2026

Tempest Therapeutics Announces Record Date for Warrant Dividends Distribution Following Asset Purchase Agreement - Quiver Quantitative

Jan 20, 2026
pulisher
Jan 20, 2026

Cancer drug developer Tempest to hand out 1:1 stock warrants - Stock Titan

Jan 20, 2026
pulisher
Jan 19, 2026

How risky is Tempest Therapeutics Inc. stock nowCEO Change & Precise Buy Zone Tips - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 19, 2026

Will Tempest Therapeutics Inc. stock pay special dividendsJuly 2025 Institutional & Entry Point Confirmation Signals - bollywoodhelpline.com

Jan 19, 2026
pulisher
Jan 18, 2026

Sentiment Review: Can Tempest Therapeutics Inc reach all time highs this yearPortfolio Update Report & Community Driven Trade Alerts - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 13, 2026

Is Tempest Therapeutics Incs growth already priced inWeekly Trend Recap & Daily Profit Focused Screening - baoquankhu1.vn

Jan 13, 2026
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
Kapitalisierung:     |  Volumen (24h):